April 19, 2024 at 01:39PM
Venture capital investors are backing BreachRx with a $6.5 million seed-stage financing. The San Francisco company plans to use the funding to expand its technology, which aims to streamline incident response reporting for corporations and shield cybersecurity executives from personal liability during data breaches. The company is also partnering with Joe Sullivan and has over 70 customers.
Key takeaways from the meeting notes are as follows:
1. BreachRx, a San Francisco-based company, secured a $6.5 million seed-stage financing from SYN Ventures and Overline, for its technology aimed at revamping corporate incident response reporting systems and providing protection from personal liability during data breaches.
2. The company’s product is designed to offer operational resilience for the entire enterprise through automated incident response plans and targeted guidance, along with integrated privileged communication channels and audit trails to ensure compliance with SEC reporting rules and changing standards.
3. BreachRx’s technology is intended to proactively safeguard Chief Information Security Officers (CISOs) and executive leadership from personal liability during cybersecurity incidents.
4. The company is collaborating with former Uber security chief Joe Sullivan to develop the product, which aims to document cross-organizational collaboration and communication in alignment with the law.
5. BreachRx currently has over 70 customers, including publicly traded and Fortune 500 companies, and plans to utilize the new funding to expand its go-to-market and engineering teams.
In addition, the meeting notes also reference related articles and topics regarding SEC cyber disclosure rules and incident response practices alignment.